349 results on '"Verslype C"'
Search Results
2. A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system
3. Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study
4. Improved survival after LTx-associated acute GVHD with mAb therapy targeting IL2RAb and soluble TNFAb: Single-center experience and systematic review
5. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
6. Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract. Initialized by the Belgian Group of Digestive Oncology (BGDO) and supported by the BGDO, the BSP (Belgian Society of Pathology) and the BCR (Belgian Cancer Registry)
7. Combined or Serial Liver and Lung Transplantation for Epithelioid Hemangioendothelioma: A Case Series
8. Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib
9. Combined Liver and Lung Transplantation With Extended Normothermic Lung Preservation in a Patient With End-Stage Emphysema Complicated by Drug-Induced Acute Liver Failure
10. SO-13 Pembrolizumab in patients with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the open-label, phase 2 KEYNOTE-224 study
11. Corrigendum to “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”
12. ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors
13. Long-term outcome of liver transplantation for unresectable liver metastases from Neuroendocrine neoplasms: a Belgian retrospective multi-centre study
14. Lessons learned about appendiceal neuroendocrine neoplasms from data analysis of the Belgian Cancer Registry 2010-2015.
15. Prevalence of microsatellite instable and Epstein-Barr Virus-driven gastro- esophageal cancer in a large Belgian cohort
16. Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts
17. Long-term outcome of liver transplantation for unresectable liver metastases from Neuroendocrine neoplasms: a Belgian retrospective multi-centre study
18. A Comparative Study of an Integrated Ultrasonic/Bipolar Sealing Device versus an Articulating Bipolar Sealing Device for Laparoscopic Liver Surgery
19. Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
20. Regression of multiple hepatocellular adenomas after cessation of oral contraceptive pills : a case report and review of the current literature
21. Evaluating the accuracy of three international guidelines in identifying the risk of malignancy in pancreatic cysts : a retrospective analysis of a surgical treated population
22. Lessons learned about appendiceal neuroendocrine neoplasms from data analysis of the Belgian Cancer Registry 2010-2015
23. 933P Updated results for pembrolizumab (pembro) monotherapy as first-line therapy for advanced hepatocellular carcinoma (HCC) in the phase II KEYNOTE-224 study
24. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008
25. 100P Hepatitis B virus (HBV)-related outcomes in patients (pts) with baseline HBV infection in the KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC)
26. The role of chemotherapy in biliary tract carcinoma
27. A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients
28. The management of locally advanced pancreatic cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 14th ESMO/World Congress on Gastrointestinal Cancer, Barcelona
29. Value of pretreatment MRI determined parameters for predicting outcome after radio-frequency ablation of hepatocellular carcinoma
30. Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi method
31. Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience
32. Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study
33. Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi method.
34. Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study
35. A Comparative Study of an Integrated Ultrasonic/Bipolar Sealing Device versus an Articulating Bipolar Sealing Device for Laparoscopic Liver Surgery
36. The management of metastatic pancreatic cancer: expert discussion and recommendations from the 14th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2012
37. Sorafenib: from literature to clinical practice
38. Hepatocellular carcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up †
39. OUTCOME AFTER LIVER TRANSPLANTATION USING CONTROLLED DONATION AFTER CARDIAC DEATH DONORS: A SINGLE-CENTER EXPERIENCE: O33-0071
40. New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel†
41. Systematic review: the pathophysiology and management of polycystic liver disease
42. Correction to: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”
43. 1003P Baseline (BL) liver function and outcomes in patients (pts) with unresectable hepatocellular carcinoma (HCC) in KEYNOTE-240
44. Predicting intra-operative outcomes in laparoscopic liver surgery using validated difficulty scores. Statistical analysis in 320 laparoscopic liver resections
45. Learning curve in laparoscopic liver surgery: A single-surgeon risk-adjusted CUSUM analysis for postoperative complications of the first 320 laparoscopic liver resections
46. One stage laparoscopic parenchymal sparing liver resection for bilobar colorectal liver metatases: Safety, recurrence patterns and oncologic outcomes
47. Prevalence of microsatellite instable and Epstein-Barr Virus-driven gastroesophageal cancer in a large Belgian cohort S.
48. Review article: blood platelet number and function in chronic liver disease and cirrhosis
49. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 29, pg iv238, 2018)
50. The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.